(Total Views: 551)
Posted On: 12/11/2019 8:46:11 PM
Post# of 153966
Here is a presentation about Leronlimab tomorrow 7-9am at San Antonio Breast Cancer Symposium
https://www.sabcs.org/Program/Spotlight-Sessi...-Session-4
Tumor Cell and Molecular Biology: Stem/Progenitor Cells
PD4-04 Leronlimab, a humanized monoclonal antibody to Ccr5, restrains breast cancer metastasis and enhances cell death induced by DNA damaging chemotherapies
Pestell RG, Cristofanilli M, Rui H, Jiao X, Wang M. Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA; Northwestern University, Chicago, IL; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
https://www.sabcs.org/Program/Spotlight-Sessi...-Session-4
Tumor Cell and Molecular Biology: Stem/Progenitor Cells
PD4-04 Leronlimab, a humanized monoclonal antibody to Ccr5, restrains breast cancer metastasis and enhances cell death induced by DNA damaging chemotherapies
Pestell RG, Cristofanilli M, Rui H, Jiao X, Wang M. Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA; Northwestern University, Chicago, IL; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
(5)
(0)
